These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2102769)
1. Secretor status and infection in patients with Graves' disease. Toft AD; Blackwell CC; Saadi AT; Wu P; Lymberi P; Soudjidelli M; Weir DM Autoimmunity; 1990; 7(4):279-89. PubMed ID: 2102769 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to Yersinia enterocolitica serotype 3 in autoimmune thyroid diseases. Takuno H; Sakata S; Miura K Endocrinol Jpn; 1990 Aug; 37(4):489-500. PubMed ID: 2083529 [TBL] [Abstract][Full Text] [Related]
3. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease. Heyma P; Harrison LC; Robins-Browne R Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to Yersinia enterocolitica in thyroid disease. Shenkman L; Bottone EJ Ann Intern Med; 1976 Dec; 85(6):735-9. PubMed ID: 1036668 [TBL] [Abstract][Full Text] [Related]
5. [Antibodies to Yersinia enterocolitica in immunogenic thyroid diseases]. Petru G; Stünzner D; Lind P; Eber O; Möse JR Acta Med Austriaca; 1987; 14(1):11-4. PubMed ID: 3618088 [TBL] [Abstract][Full Text] [Related]
6. Yersinia enterocolitica and thyroid autoimmunity. Bech K Autoimmunity; 1990; 7(4):291-4. PubMed ID: 2102770 [TBL] [Abstract][Full Text] [Related]
7. Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves' disease: evidence from a twin case-control study. Brix TH; Hansen PS; Hegedüs L; Wenzel BE Clin Endocrinol (Oxf); 2008 Sep; 69(3):491-6. PubMed ID: 18284638 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. Arscott P; Rosen ED; Koenig RJ; Kaplan MM; Ellis T; Thompson N; Baker JR J Clin Endocrinol Metab; 1992 Jul; 75(1):295-300. PubMed ID: 1619022 [TBL] [Abstract][Full Text] [Related]
9. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Corapçioğlu D; Tonyukuk V; Kiyan M; Yilmaz AE; Emral R; Kamel N; Erdoğan G Thyroid; 2002 Jul; 12(7):613-7. PubMed ID: 12193307 [TBL] [Abstract][Full Text] [Related]
10. Thyrotropin receptor antibodies in parotid saliva. Tumilasci OR; Arqueros MC; Ostuni MA; el Tamer E; Houssay AB J Endocrinol Invest; 1996; 19(7):412-4. PubMed ID: 8884533 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156 [TBL] [Abstract][Full Text] [Related]
12. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools. Wang Z; Zhang Q; Lu J; Jiang F; Zhang H; Gao L; Zhao J J Clin Endocrinol Metab; 2010 Aug; 95(8):4012-20. PubMed ID: 20484489 [TBL] [Abstract][Full Text] [Related]
13. Incidences of antibodies to Yersinia enterocolitica: high incidence of serotype O5 in autoimmune thyroid diseases in Japan. Asari S; Amino N; Horikawa M; Miyai K Endocrinol Jpn; 1989 Jun; 36(3):381-6. PubMed ID: 2583057 [TBL] [Abstract][Full Text] [Related]
14. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of Yersinia enterocolitica envelope proteins which induce antibodies that react with human thyrotropin receptor. Luo G; Seetharamaiah GS; Niesel DW; Zhang H; Peterson JW; Prabhakar BS; Klimpel GR J Immunol; 1994 Mar; 152(5):2555-61. PubMed ID: 7510749 [TBL] [Abstract][Full Text] [Related]
16. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema. Arnold K; Metcalfe R; Weetman AP J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579 [TBL] [Abstract][Full Text] [Related]
18. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377 [TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on autoimmune mechanisms of the thyroid Part II. Leucocyte migration inhibiton studies in Hashimoto's thyroiditis and in Graves' disease (author's transol)]. Ikekubo K Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):840-55. PubMed ID: 1243915 [TBL] [Abstract][Full Text] [Related]
20. Patients with autoimmune thyroid diseases have antibodies to plasmid encoded proteins of enteropathogenic Yersinia. Wenzel BE; Heesemann J; Wenzel KW; Scriba PC J Endocrinol Invest; 1988 Feb; 11(2):139-40. PubMed ID: 3361082 [No Abstract] [Full Text] [Related] [Next] [New Search]